Navigating the CMS 14-Day Rule in Biomarker Testing

David L. Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

Related Videos

March 31, 2015

Value in Cancer Care

Alexander Bastian discusses the critical nature of value and cost-effectiveness in cancer care, which he says is a difficult challenge and must include patients and providers.

January 20, 2016

How to Identify a Cancer Stem Cell

Dr Wainberg and Dr Gerson discuss how biomarkers may help identify cancer stem cells.